检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张玉玲 和芳娟 Zhang Yuling;He Fangjuan(Second Department of Cardiology,Affiliated Hospital of Gansu University of Chinese Medicine,Lanzhou 730030,Gansu Province,China;Department of Internal Medicine,Lanzhou Petrochemical General Hospital,Lanzhou 730030,Gansu Province,China)
机构地区:[1]甘肃中医药大学附属医院心血管科二科,兰州730030 [2]兰州石化总医院内科,兰州730030
出 处:《中国基层医药》2025年第2期313-316,共4页Chinese Journal of Primary Medicine and Pharmacy
摘 要:脂必泰胶囊具有调节血脂、预防心血管疾病、保护肝脏等特点, 临床应用较为广泛。脂必泰联合小剂量他汀类药物治疗冠心病患者, 其降脂效果与大剂量他汀类药物相当, 且不良反应发生率更低。因此本研究从脂必泰胶囊的药物成分、作用机制、临床应用、不良反应及安全性等方面进行综述, 从而为临床应用脂必泰调脂提供理论支持。Zhibitai Capsules are characterized by their ability to regulate blood lipids,prevent cardiovascular diseases,and protect the liver,making them widely used in clinical practice.When combined with low-dose statins for the treatment of coronary artery disease,their lipid-lowering effect is comparable to that of high-dose statins,while exhibiting a lower incidence of adverse reactions.Therefore,this study reviews the drug components,mechanisms of action,clinical applications,adverse reactions,and safety of Zhibitai Capsules,providing theoretical support for their clinical use in lipid regulation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7